Showing all 15 results
Afatinib is used to treat a certain type of non-small cell lung cancer that has spread to other parts of the body. Afatinib is used for this condition only if your tumor has a specific genetic marker for which your doctor will test.
Afatinib is also used to treat squamous non-small cell lung cancer that has spread to other parts of the body after other cancer medicine has been tried without successful treatment.
Afatinib may also be used for purposes not listed in this medication guide.
Crizotinib is used to treat non-small cell lung cancer that has spread to other parts of the body.
Crizotinib may also be used for purposes not listed in this medication guide.
DASA-20 Dasatinib is a medicine that targets specific proteins in cancer cells and stops the cancer cells
from growing. It is used to treat some kinds of leukemia.
Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body.
Dasatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective.
Dasatinib may also be used for purposes not listed in this medication guide.
Gefitinib is an oral small molecule EGFR inhibitor that is approved for the therapy of metastatic non-small cell lung cancer. Side effects are usually dose related mild to moderate,
Imatinib is a prescription medication used to treat Acute Lymphoblastic Leukemia, Myelodysplastic/Myeloproliferative Disease, Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukemia, Chronic Myeloid Leukemia Philadelphia-Chromosome-Positive, Dermatofibrosarcoma Protuberans, Mastocytosis, and Gastrointestinal Stromal Tumors.
LENVACAP® (lenvatinib), a prescription medicine that may help treat people with certain kinds of cancer.
Nilotinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML).
Nilotinib is usually given after other medications have been tried without success.
Nilotinib may also be used for purposes not listed in this medication guide.
OSIM-40 Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR).
OSIM-80 (Osimertinib)/ Azd9291 is kinase inhibitor of the epidermal growth factor receptor (EGFR).
Sorafenib is an oral targeted kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), unresectable hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant differentiated thyroid cancer.
Sunitinib is used to treat certain types of advanced or progressive tumors of the digestive system, the pancreas, or the kidneys.
Sunitinib may also be used for purposes not listed in this medication guide.
Sunitinib is used to treat certain types of advanced or progressive tumors of the digestive system, the pancreas, or the kidneys.
Sunitinib may also be used for purposes not listed in this medication guide.
Sunitinib is used to treat certain types of advanced or progressive tumors of the digestive system, the pancreas, or the kidneys.
Sunitinib may also be used for purposes not listed in this medication guide.